Femasys to participate in 78th annual american society for reproductive medicine (asrm) scientific congress

Atlanta, oct. 14, 2022 (globe newswire) -- femasys inc. (nasdaq: femy), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the company's management team will be attending the 78th annual american society for reproductive medicine (asrm) scientific congress to be held in anaheim, california from october 22-26, 2022.
FEMY Ratings Summary
FEMY Quant Ranking